Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim

Make Better Decisions, Faster

Special Academic / Government / Non-Profit Pricing

Most Popular

Pharmaceutical Drugs


  • Expired, Pending, and Abandoned Patents
  • Active US & International Patents
  • Single Source Drugs, Tentative Approvals, Authorized Generics, Paragraph IV Challenges, and more…
  • Clinical Trials
  • API Vendors


Biologic Drugs


  • US & International Patents
  • Manufacturers
  • Suppliers


Drugs In Development


  • Drug Candidates in Phase I-III Clinical Trials
  • Expired, Pending, and Abandoned Patents
  • Active US & International Patents
  • Clinical Trial Progress
  • API Vendors

US Drug Patent Litigation


  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board

US Drug Prices


  • Brand vs. Generic Drug Price
  • Average Pharmacy Cost
  • Best-Available Price

US Drug Sales


  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

Clients in 66 Countries

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Frequently Asked Questions

For which countries does DrugPatentWatch have patent information?

DrugPatentWatch has patent coverage for the following countries and regional organizations:

African Intellectual Property Organization (OAPI) African Regional IP Organization (ARIPO) Algeria Argentina Australia Austria Belgium Benin (OAPI) Bosnia and Herzegovina Botswana (ARIPO) Brazil Bulgaria Burkina Faso (OAPI) Cameroon (OAPI) Canada Central African Republic (OAPI) Chad (OAPI) Chile China Colombia Comoros (OAPI) Congo-Brazzaville (OAPI) Costa Rica Croatia Cuba Cyprus Czech Republic Czechoslovakia Côte d'Ivoire (OAPI) Denmark Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea (OAPI) Estonia Eurasian Patent Organization European Patent Office Finland France Gabon (OAPI) Georgia, Republic of German Democratic Republic Germany Ghana (ARIPO) Greece Guatemala Guinea (OAPI) Guinea-Bissau (OAPI) Gulf Cooperation Council Honduras Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Jordan Kenya (ARIPO) Latvia Lesotho (ARIPO) Liberia (ARIPO) Lithuania Luxembourg Malawi (ARIPO) Malaysia Mali (OAPI) Mauritania (OAPI) Mexico Moldova, Republic of Monaco Montenegro Morocco Mozambique (ARIPO) Namibia (ARIPO) Netherlands New Zealand Nicaragua Niger (OAPI) Norway Panama Peru Philippines Poland Portugal Romania Russian Federation Rwanda (ARIPO) San Marino Saudi Arabia Senegal (OAPI) Serbia Sierra Leone (ARIPO) Singapore Slovakia Slovenia Somalia (ARIPO) South Africa South Korea Spain Sudan (ARIPO) Swaziland (ARIPO) Sweden Switzerland São Tomé and Príncipe (ARIPO) Taiwan Tajikistan Tanzania (ARIPO) The Gambia (ARIPO) Togo (OAPI) Tunisia Turkey Uganda (ARIPO) Ukraine United Kingdom United States of America Uruguay Viet Nam Yugoslavia Zambia (ARIPO) Zimbabwe (ARIPO)

What kind of email alerts can I have?

Adding an alert is as easy as clicking the 'Add Alert' button beside any table of interest.

    Available alerts include:

  • Paragraph IV challenges
  • New drugs and added or expired patents per company
  • Added or expired patents per drug
  • Tentative approvals

How many users can share an account

Enterprise Plans are available for unlimited users within your organization. The other plans are for single users, but multiple accounts can be purchased for a substantial discount. For more information on enterprise plans, please contact us

I need a pro forma invoice so I can pay by EFT/check. Who should I contact?

Please use the contact form and tell us which subscription plan you would like an invoice for.

I have another question

No problem. Please use the contact form and let us know how we can be of assistance.